Patents by Inventor George N. Cox, III

George N. Cox, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6785613
    Abstract: The invention provides criteria and methods for selecting optimum subsequence(s) from a target gene for targeting by a zinc finger protein. Some of the methods of target site selection seek to identify one or more target segments having a DNA motif containing one or more so-called D-able subsites having the sequence 5′NNGK3′. Other methods of the invention are directed to selection of target segments within target genes using a correspondence regime between different triplets of three bases and the three possible positions of a triplet within a nine-base site. In another aspect, the invention provides methods of designing zinc finger proteins that bind to a preselected target site. These methods can be used following the preselection of target sites according to the procedures and criteria described above. The methods of design use a database containing information about previously characterized zinc finger proteins.
    Type: Grant
    Filed: March 28, 2002
    Date of Patent: August 31, 2004
    Assignee: Sangamo Biosciences, Inc.
    Inventors: Stephen P. Eisenberg, Casey C. Case, George N. Cox, III, Andrew Jamieson, Edward J. Rebar
  • Patent number: 6608183
    Abstract: The growth hormone supergene family comprises greater than 20 structurally related cytokines and growth factors. A general method is provided for creating site-specific, biologically active conjugates of these proteins. The method involves adding cysteine residues to non-essential regions of the prr teins or substituting cysteine residues for non-ssential amino acids in the proteins using site-directed mutagenesis and then covalently coupling a cysteine-reactive polymer or other type of cysteine-reactive moiety to the proteins via the added cysteine residue. Disclosed herein are preferred sites for adding cysteine residues or introducing cysteine substitutions into the proteins, and the proteins and protein derivatives produced thereby.
    Type: Grant
    Filed: January 14, 2000
    Date of Patent: August 19, 2003
    Assignee: Bolder Biotechnology, Inc.
    Inventor: George N. Cox, III
  • Patent number: 6607882
    Abstract: The present invention provides methods for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.
    Type: Grant
    Filed: January 6, 2000
    Date of Patent: August 19, 2003
    Assignee: Sangamo BioSciences, Inc.
    Inventors: George N. Cox, III, Casey C. Case, Stephen P. Eisenberg, Eric E. Jarvis, Sharon K. Spratt
  • Patent number: 6453242
    Abstract: The invention provides criteria and methods for selecting optimum subsequence(s) from a target gene for targeting by a zinc finger protein. Some of the methods of target site selection seek to identify one or more target segments having a DNA motif containing one or more so-called D-able subsites having the sequence 5′NNGK3′. Other methods of the invention are directed to selection of target segments within target genes using a correspondence regime between different triplets of three bases and the three possible positions of a triplet within a nine-base site. In another aspect, the invention provides methods of designing zinc finger proteins that bind to a preselected target site. These methods can be used following the preselection of target sites according to the procedures and criteria described above. The methods of design use a database containing information about previously characterized zinc finger proteins.
    Type: Grant
    Filed: January 12, 1999
    Date of Patent: September 17, 2002
    Assignee: Sangamo Biosciences, Inc.
    Inventors: Stephen P. Eisenberg, Casey C. Case, George N. Cox, III, Andrew Jamieson, Edward J. Rebar